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Summary
To achieve the greatest output from their limited ge-
nomes, viruses frequently make use of alternative
open reading frames, in which translation is initiated
from a start codon within an existing gene and, being
out of frame, gives rise to a distinct protein product.
These alternative protein products are, as yet, poorly
characterized structurally. Here we report the crystal
structure of ORF-9b, an alternative open reading frame
within the nucleocapsid (N) gene from the SARS coro-
navirus. The protein has a novel fold, a dimeric tent-
likebstructurewith anamphipathic surface, and acen-
tral hydrophobic cavity that binds lipid molecules.
This cavity is likely to be involved inmembrane attach-
ment and, inmammalian cells, ORF-9b associates with
intracellular vesicles, consistent with a role in the as-
sembly of the virion. Analysis of ORF-9b and other
overlapping genes suggests that they provide snap-
shots of the early evolution of novel protein folds.
Introduction
To achieve expression of viral proteins during infection,
viruses exploit many aspects of the host biology, such
as transcription (McKnight and Tjian, 1986), RNA export
(Harris and Hope, 2000), capping and methylation (Cou-
got et al., 2004), as well as translation (Sonenberg and
Dever, 2003). Viruses also use specific strategies, such
as RNA editing (Turelli and Trono, 2005) and splicing
(Pongoski et al., 2002), to enrich the diversity of viral pro-
teins produced from the usually rather small viral ge-
nome. A particularly bizarre phenomenon, especially in
RNA viruses, is the use of multiple start codons within
a gene which gives rise to different protein products
(Samuel, 1989). The presence of these so-called alterna-
tive open reading frames (ORFs) and their translation
has been shown to occur by several mechanisms (re-
viewed in Jackson, 1996): leaky scanning, where the
usual start codon of a gene is in an unfavorable se-
quence context, so that a fraction of ribosomal scanning
complexes fail to initiate and continue scanning to the
next start codon; internal ribosome entry sites; ribo-
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3 Lab address: http://www.strubi.ox.ac.uksomal shunting (where, during scanning, ribosomal
complexes translocate to a remote position on the
mRNA and initiate translation there); and translational
reinitiation after termination.
Alternative ORFs and their mechanisms of transla-
tional initiation have been described in many viral sys-
tems, including influenza B (Shaw et al., 1983), Sendai
virus (Giorgi et al., 1983), and reovirus (Ernst and Shat-
kin, 1985; Jacobs and Samuel, 1985), as well as group
2 coronaviruses, such as mouse hepatitis virus (MHV)
and bovine coronavirus (BCV) (Fischer et al., 1997; Sen-
anayake and Brian, 1997). So far, most of the research
on alternative ORFs has focused on the mechanisms
for initiation of translation, while the molecular struc-
tures and functions of the corresponding proteins have
received little attention. This is somewhat surprising,
given that the special nature of such proteins (each aris-
ing from a ‘‘gene inside another gene’’) is likely to give
new insights into protein structure and evolution.
Recently, a coronavirus was identified as the causa-
tive agent of an emerging disease, severe acute respira-
tory syndrome (SARS) (Ksiazek et al., 2003). During its
first outbreak in 2003, SARS led to at least 8000 infec-
tions and over 750 fatalities (Donnelly et al., 2003). The
SARS coronavirus (SARS-CoV) genome consists of
approximately 29,700 nucleotides encoding a predicted
28 proteins (Marra et al., 2003; Rota et al., 2003), includ-
ing several alternative ORFs. These occur in the 30 region
of the genome, which encodes structural and accessory
proteins that are involved in the assembly of the virus
particle (see Figure 1). Although the precise details of
coronavirus assembly are not well understood, the con-
sensus model is that the RNA genome is packaged in the
cell cytoplasm by multiple copies of the relatively well
conserved (Stadler et al., 2003) N-protein to form the nu-
cleocapsid. The nucleocapsid then associates with the
viral membrane proteins M, S, and E in the ER-to-Golgi
intermediate compartment, where virus particles as-
semble and bud into the Golgi. In SARS-CoV, as in other
group 2 coronaviruses, an additional protein is synthe-
sized (called ORF-9b in SARS-CoV and internal or I-pro-
tein otherwise) from an alternative reading frame of the
N-gene. In BCV, the I-protein is produced in an exact
molar ratio with the N-protein (Senanayake and Brian,
1997) and in MHV it is present in the assembled virion,
suggesting that it acts as an accessory structural pro-
tein in viral assembly (Fischer et al., 1997). The MHV
I-protein is not essential for the production of viable
virus; however, it does confer a selective advantage
for virus growth (Fischer et al., 1997). Although little is
known about the equivalent protein in SARS Co-V, anti-
bodies against ORF-9b have been found in patients,
demonstrating that it is produced during infection (Qiu
et al., 2005).
We are pursuing an investigation into the structures of
proteins from SARS-CoV (Sutton et al., 2004). Here we
report the crystal structure of ORF-9b, which we demon-
strate functions as an unusual lipid binding protein and
possesses a novel fold. In addition, we show that
ORF-9b expressed in mammalian cells colocalizes
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1158Figure 1. The Structure of the SARS-CoV
Genome
Alternative open reading frames (ORF-3b,
-7b, -8b, and -9b) are highlighted in gray.
The nucleocapsid (N) gene including its inter-
nal alternative open reading frame, ORF-9b,
is shown in an enlarged representation. S,
spike protein; 3, ORF-3; E, envelope protein;
M, membrane protein; 6, ORF-6; 7, ORF-7;
8, ORF-8; N, nucleocapsid protein (adapted
from Snijder et al., 2003; genome representa-
tion is not to scale).with cellular vesicles, indicating a role in virus assembly
via membrane association. To our knowledge, the struc-
ture represents the first example of a viral protein trans-
lated as an alternative open reading frame elucidated at
high resolution, and we suggest that its unusual features
may reflect its recent evolutionary origin.
Results and Discussion
Structure Determination
The structure of ORF-9b was solved by single-wave-
length anomalous dispersion (SAD) analysis of a seleno-
methionated form of the protein expressed in Escheri-
chia coli (see Experimental Procedures and Table 1 for
details). The crystals diffracted X-rays weakly (overall
B factor 84 A˚2), limiting the analysis to Bragg spacings
of 2.8 A˚ (R = 26.6%, Rfree = 28.9%), and a significant por-
tion of the structure is not well ordered. Nevertheless,
due to the presence of 8-fold noncrystallographic sym-
metry, we can be confident that the interpretation of
the structure is reliable.
The Protein Fold
The crystal structure reveals ORF-9b to be a 2-fold sym-
metric dimer constructed from two adjacent twisted
b sheets (Figure 2A). Each of these sheets is formed
from b strands contributed by both monomers which
form a highly interlocked architecture reminiscent of
a handshake (Figure 2B). These extensive interactions
bury over 1500 A˚2 of surface area of each subunit on for-
mation of the dimer (calculated with NACCESS; Hub-
bard et al., 1991), typical of the contact area of protein
dimers (Lesk, 2004), strongly suggesting a biologically
relevant interaction. The hydrodynamic properties of
the protein in solution (determined by dynamic light
scattering and analytical ultracentrifugation; see the
Supplemental Data available with this article online)
are consistent with it being a dimer.
The interdigitated nature of the ORF-9b dimer rests on
a highly unusual topology of largely antiparallel b sheets
in which monomers wrap around each other (Figure 2B).
A search of the protein database with both the monomer
and dimer using Dali (Holm and Sander, 1993) and SSM
(Krissinel and Henrick, 2004) gave no significant struc-
tural hits. This suggests that the structure represents
a novel fold.
Analysis of the surface electrostatics of ORF-9b
shows a highly polarized distribution, in which one side
of the molecule is predominantly negatively chargedwhile the other is positively charged (Figure 2C). It is
interesting to note that in the electron density map, two
regions near the N terminus (residues 1–8 and 26–37)
are not resolved. Both of these disordered segments
are located on the periphery of the structure, whereas
the inner core of the protein is reasonably well ordered.
The crystal of the protein is built up from twisted
chains of ORF-9b dimers that form an open three-
dimensional mesh, via end-to-end packing of dimers
via the b4b5 and b6b7 loops (Figure 2D), to occlude
some 700 A˚2 of surface area from each dimer.
Table 1. Crystallographic Data Recording, Model Building, and
Refinement Statistics
Data Collection
Experiment Single-wavelength
anomalous dispersion
X-ray source ESRF BM14
Wavelength 0.97903
Resolution (A˚) 19.9–2.8 (2.9–2.8)
Unique reflections 22,040
Redundancy 14.9 (15.1)
Completeness 99.8 (100)
Rmerge
a (%) 11.1 (b)
I/s(I) 22.8 (1.3)
Space group P42
Unit cell parameters (A˚) a = b = 140.1, c = 45.2
No. of molecules (AU) 8
Solvent content (%) 52
Refinement
R value (%) 26.6 (40.4)
Free R value, random 5% (%) 28.9 (43.2)
Rmsd bond length (A˚) 0.009
Rmsd bond angle (º) 1.8
Rmsd B, bonded atoms (A˚2) 7
Rmsd Ca, corec (A˚) 0.25
Rmsd Ca, overallc (A˚) 4.6
Ramachandran plot
Allowed regions 97.3%
Generously allowed regions 1.5%
Disallowed regions 1.3%
Values in parentheses refer to the highest resolution shells.
a Rmerge = ShSi jIi (h) 2 <I(h)>j / ShSi <Ii (h) >, where Ii (h) is the ith
measurement and <I(h)> is the weighted mean of all measurements
of Ii (h).
b The R factor for the highest resolution shell exceeds 100%, as
expected from the extreme weakness of the data (B factor from
the Wilson plot, 84 A˚2); however, the very high redundancy (15)
allows some useful data to be obtained in this shell.
c Core regions exclude the flexiblew4 N-terminal residues and flex-
ible loops: 24–41 (residues 26–37 are not modeled), 48–52, 64–71,
89–91.
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SARS-CoV ORF-9b Protein
(A) Cartoon representation. Two orthogonal
views are presented. In the electron density
map, residues 9–25 and 38–98 are resolved.
The secondary structural elements are la-
beled for one subunit in the upper image, b1
13–16, b2 19–24, b3 42–50, b4 53–61, b5 69–
75, b6 79–82, and b7 90–98. The lipid ligand
is shown as yellow van der Waals radii
spheres. The 2-fold symmetry axis is indi-
cated.
(B) Topology diagram illustrating the inter-
locked architecture of the dimeric structure.
Monomers are colored gray and cyan. Disor-
dered regions are represented as dashed
lines.
(C) Surface electrostatic representation. In
this view, the top of the structure is predom-
inantly negatively charged (red), and the bot-
tom is mainly positively charged (blue). The
arrow indicates the opening of the hydropho-
bic tunnel.
(D) Crystal contacts between ORF-9b mole-
cules. Neighboring dimers are rotated w90º
around their longest axis, and pack end to
end via their b4b5 and b6b7 loops. This gives
rise to an assembly reminiscent of a twisted
rope.
(E) Sequence alignment of SARS coronavirus
ORF-9b and its homologs in mouse hepatitis
virus (MHV) and bovine coronavirus (BCV).
The alignment was performed using MultAlin
(Corpet, 1988) and due to the very low level of
sequence similarity should be regarded as
provisional, pending a proper structure-
based analysis. Residue numbering refers to
the ORF-9b protein from SARS-CoV. Protein
secondary structure is represented as yellow
arrows (b strands), solid lines (random coil
conformation), and dotted lines (disordered
regions). Residues which line the hydropho-
bic tunnel of ORF-9b are highlighted in green.
Magenta bars indicate residues which vary
between different SARS isolates (see Supple-
mental Data for a detailed alignment). The fig-
ure was produced with ESPript (Gouet et al.,
1999).A Hydrophobic Tunnel
The b sheets of ORF-9b form a tent-like structure which
contains a 22 A˚ long central cavity, lined by hydrophobic
side chains, which spans the molecule and is open at
both ends (Figures 2E, 3A, and 3B). Within this tunnel,
the experimentally phased map shows a finger of elec-
tron density (Figure 3A) straddling the molecular dyad,
separate from the protein portion of the map. Given
the hydrophobic nature of the cavity, we interpreted
this feature as an aliphatic molecule bound within the
ORF-9b dimer. For the purpose of crystallographic
model building and refinement, we have represented
this ligand as a hydrocarbon molecule (the resolved
electron density is consistent with an unbranched chain
of ten carbon atoms; see Figures 3A and 3B).
In order to identify the molecule bound in the tunnel,
we carried out a mass spectrometry analysis (shown in
Figure 3C) which revealed a single molecular species
of molecular weight 414 Da, significantly larger than ex-
pected from the visible electron density. The mass spec-
trometry data suggest that the ligand is a fatty acid(or fatty acid ester) containing approximately 25 carbon
atoms. This is entirely consistent with the open architec-
ture of the hydrophobic pocket of ORF-9b, which would
allow such large hydrophobic molecules to be accom-
modated, with atoms hanging from the end(s) of the tun-
nel (invisible in our crystallographic analysis due to flex-
ibility). The mass analysis is incompatible with the ligand
being derived from the detergent present during cell
lysis. This suggests that the ligand was picked up from
the bacterial expression host and is tightly bound so
that it remains associated with the ORF-9b protein dur-
ing purification. In order to establish whether this was an
artifact of the expression system used, refolding exper-
iments (see Experimental Procedures) were performed,
which demonstrated that—in the absence of lipid—the
protein folds into molecules with hydrodynamic proper-
ties identical to those of the lipid-bound structure. Fur-
thermore, thermostability assays (see Figure 3D) show
that refolded, lipid-free ORF-9b is slightly less stable
than that purified from E. coli, consistent with lipid bind-
ing representing a thermodynamic phenomenon.
Structure
1160Figure 3. Lipid Binding of ORF-9b
(A) The protein structure is cut in the center and viewed along its longest axis to reveal the central hydrophobic tunnel. The crystallographically
resolved portion of the ligand is shown in yellow; the experimentally phased electron density (contoured at 1s) is shown in green. The 2-fold
symmetry axis lies in the plane of the paper, as indicated.
(B) Cartoon of the residues lining the lipid binding pocket. The lipid is shown in ball-and-stick representation and the residues contributed by the
two subunits are distinguished by the color of their contact symbols.
(C) Mass spectrum of the extracted ligand molecule (designated M). Its molecular weight is 414 Da. In the mass spectrum, three significant peaks
are observed, suggestive of proton (+1 Da), sodium (+23 Da), and potassium (+39 Da) adducts of a fatty acid molecule. The observed mass is
consistent with a saturated long-chain hydroxy fatty acid C25H50O4 (mass 413 Da), such as dihydroxy-pentacosanoate, or a nonhydroxy fatty
acid ester C25H50O4 (mass 413 Da) (Christie, 1982).
(D) ThermoFluor assay result for natively purified (lipid-containing) and refolded (lipid-free) ORF-9b. In both cases, there is a strong fluorescence
peak at 65ºC–70ºC, which presumably represents the collapse of the dimeric ORF-9b structure. Refolded ORF-9b peaks at 66ºC, whereas
natively purified ORF-9b has a peak at 69ºC, demonstrating that lipid-containing ORF-9b is slightly more stable than ORF-9b without lipid, sug-
gesting that the lipid has a thermodynamically stabilizing effect on the protein.
(E) Proposed mode of ORF-9b membrane interaction (protein structure represented as in Figure 2B, but rotated by 90º around the vertical 2-fold
symmetry axis). The positively charged side of the protein (shown in blue) could interact with the negatively charged lipid head groups, while the
hydrophobic pocket (indicated by dashed lines) binds one or more lipid tails.Given the width of the tunnel, it is likely that ORF-9b
can accommodate bulkier or irregularly shaped mole-
cules (for instance, unsaturated lipid chains). In fact, in
the crystal structure presented here, the bound ligand
occupies under half of the volume of the pore. This is
considerably less than for other lipid binding proteins,
which have more tight-fitting hydrophobic pockets
(see Table 2).
An Unusual Type of Membrane Binding Protein
Expression in mammalian cells (see Experimental Pro-
cedures) reveals that ORF-9b is membrane bound and
appears to be associated with intracellular vesicular
structures (Figures 4A and 4B). Given that expression
of the protein in E. coli gives soluble protein, this sug-
gests that ORF-9b specifically recognizes and binds to
intracellular membranes in eukaryotes.
Considering the polarized surface and hydrophobic
tunnel of the protein, it is most likely that the ORF-9bmolecule immerses itself in the lipid head groups of
the membrane and becomes anchored by internalizing
one or more lipidic tails (illustrated in Figure 3E). This
would be the opposite of the more usual covalent at-
tachment of lipid tails to proteins, and would represent
an unusual mode of membrane interaction. Indeed, we
are aware of only one similar example in the litera-
ture—that of the conserved eukaryotic protein bet3,
which appears to interact with the Golgi by binding
myristate chains of the phospholipid bilayer in a well-
defined pocket (Kim et al., 2005).
Function of the Protein in the Life Cycle
of the SARS Virus
At present, there is little published work on ORF-9b, so
the precise function of the protein remains uncertain.
Most of our current knowledge comes from homologous
gene products in other coronaviruses, most importantly
the work on MHV and BCV discussed above, where the
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1161Table 2. A Comparison of the Hydrophobic Pockets of Different Types of Lipid Binding Proteins
Protein Structure
PDB Code
(Literature Reference) Type of Ligand
Volume of
the Pore (A˚3)
Volume of the Ligand
in the Pore (A˚3)
Percentage of
Pore Occupied
SARS-CoV ORF-9b 2CME Long-chain fatty acid 365 166 45%
Human CD1b 1GZP (Gadola et al., 2002) Ganglioside GM2 (glycolipid) 1564 881 56%
Poliovirus 2PLV (Filman et al., 1989) Sphingosine (long-chain
amino alcohol)
292 176 60%protein has been shown to be present as a structural
component in the virus particle (Fischer et al., 1997)
and is likely to be an accessory protein in virus assem-
bly. Because the protein occurs as an alternative open
reading frame of the viral nucleocapsid gene, it has
been suggested to serve as an interaction partner of
the corresponding N-protein (Senanayake and Brian,
1997).
Combining these observations with our structural and
functional studies, it seems plausible that ORF-9b has
a role in membrane interactions during the assembly
of the virus (although other possible functions cannot
be ruled out). It could act as an attachment point onto
the membrane for other proteins, such as the N-protein,
which is known to bind to membranes via protein-
protein interactions, even though the details are not
well understood at present (de Haan and Rottier,
2005). Alternatively, ORF-9b could act as a modulator
of membranes themselves, for example by promoting
vesicle formation and budding (both of which are key
stages in the assembly of coronaviruses). In this regard
the higher order assembly of ORF-9b in the crystal, as
interconnected twisted ropes (see Figure 2D), may be
partially recapitulated at the membrane surface, impart-
ing some torque on the membrane. The possible role of
ORF-9b in the assembly of the SARS virus is illustrated
in Figure 4C.The Evolution of ORF-9b and Homologs in Other
Coronaviruses
The sequence of ORF-9b is well conserved in different
SARS isolates (see Supplemental Data). As discussed
above, several other, mainly group 2, coronaviruses
(e.g., MHV and BCV) also have an alternative ORF in their
nucleocapsid gene. There is good sequence conser-
vation of the alternative ORF in these group 2 coronavi-
ruses, but rather little similarity with SARS-CoV ORF-9b
(see Figure 2E). This intermediate relationship reflects
the evolution of SARS-CoV, which has been suggested
to be an early split-off from the group 2 coronavirus sub-
family (see Figure 5A) (Snijder et al., 2003). Functionally,
the ORF-9b homolog of MHV acts as an accessory
structural protein that is not essential for viral infection
but confers a small growth advantage (Fischer et al.,
1997), presumably explaining why non-group 2 corona-
viruses can function without the protein. Taken together,
these observations argue that the internal ORF of the
N-gene of group 2 coronaviruses evolved after the
N-protein (which, in contrast, is present and reasonably
conserved in all coronaviruses; Stadler et al., 2003). The
most likely mechanism by which such an alternative
ORF could arise would be as an ‘‘accidental’’ mistrans-
lation of the N-gene that subsequently evolved into
a structured and functional protein (Figure 5B). This
hypothesis is consistent with the crystal structureFigure 4. Expression and Intracellular Loca-
tion of ORF-9b in 293T Mammalian Cells
(A) Differential interference contrast micros-
copy (gray) overlapped with epifluorescence
using an anti-His fluorochrome-conjugated
monoclonalantibody (red).Theprotein isasso-
ciated with intracellular vesicular structures.
(B) Partitioning experiment, in which the 293T
cells expressing ORF-9b were fractionated
into soluble (cytosolic) and insoluble/noncy-
tosolic (nuclear, intravesicular, membrane-
associated) phases. Western blotting with
a specific antibody shows that ORF-9b is in
the insoluble fraction, most likely membrane
attached as suggested by (A). M, molecular
weight markers; I, insoluble phase; S, soluble
phase.
(C) Cartoon representation of the intracellular
localization of ORF-9b (red dots) and its pos-
sible function in the assembly of the SARS
coronavirus. In this model, ORF-9b is located
on the cytosolic side of intracellular vesicles,
serving as an attachment point for compo-
nents of the nascent virus and/or as a modula-
tor of membranes. Currently it is unknown
whether ORF-9b is present in the assembled
virus particle; however, the homologous pro-
tein is known to be present in particles of
MHV (Fischer et al., 1997).
Structure
1162Figure 5. The Structural Evolution of Alternative Open Reading Frames in Viruses
(A) The evolution of coronaviruses (adapted from Snijder et al., 2003). Based on their genome sequence, coronaviruses fall into three main
groups. SARS-CoV is thought to be an early split-off from the group 2 lineage (indicated by a dashed circle). Alternative open reading frames
of the nucleocapsid gene are found only in group 2 viruses, such as MHV and BCV (Senanayake and Brian, 1997), as well as group 2-related
viruses, including SARS-CoV. BCV, bovine coronavirus; HCoV-229E, human coronavirus 229E; IBV, infectious bronchitis virus; MHV, murine
hepatitis virus; PDEV, porcine epidemic diarrhea virus; SARS-CoV, severe acute respiratory syndrome coronavirus; TGEV, transmissible gastro-
enteritis virus.
(B) A model for the structural evolution of ORF-9b within the SARS-CoV N-gene. Starting from an N-gene without an alternative ORF, the protein
first arises as an ‘‘accidental’’ translation product, which is mostly unstructured. By gradual constrained evolution, it becomes increasingly struc-
tured, eventually attaining its present fold. In this scheme, disordered regions (colored in red) are a relict of the evolutionary trajectory of the pro-
tein. The N-protein is represented as a composite of two NMR structures of its well-conserved N- and C-terminal domains (Chang et al., 2005a;
Huang et al., 2004), which are thought to be surrounded by flexible linkers (Chang et al., 2005b) (colored in red). The region of the N-terminal
domain which overlaps with ORF-9b is shown in green.
(C) For comparison, an illustration of the HIV1 vpu and env genes, which partially overlap. The NMR structure of the overlapping portion of VPU
(Willbold et al., 1997) (PDB code: 1VPU) is shown. This protein is relatively poorly ordered (rmsd = 1.6 A˚ between multiple determinations of the
fold, for all Ca atoms). The least ordered regions (rmsd > 2 A˚) are highlighted in red.presented here, as, to our knowledge, there is no evi-
dence that it resembles any other known protein fold.
Implications for the Structural Evolution of
Alternative Open Reading Frames
Alternative open reading frames are coupled to their cor-
responding ‘‘conventional’’ reading frame on a genetic
level (in the case of ORF-9b, the conventional ORF is
the SARS-CoV N-protein). Changes in the DNA se-
quence will therefore affect both the conventional and
alternative ORF, limiting the rate and extent to which
the corresponding proteins can evolve. The result will
be a ‘‘constrained evolution,’’ an idea which has been
demonstrated for regions of viral genes which (partially)overlap (Mizokami et al., 1997). Because ORF-9b is en-
tirely contained within its corresponding conventional
gene, the constraint applies to the entire protein. The
properties of coupled gene products are likely to be
suboptimal compared to proteins that can evolve inde-
pendently. In the early stages of the evolution of the
alternative reading frame, this protein might be ex-
pected to be rather poorly folded, whereas eventually
there would presumably be a balance, struck by selec-
tion, with both protein products being somewhat com-
promised. Thus, the structural disorder observed in
ORF-9b (evinced in the considerable divergence of the
eight noncrystallographically related molecules; see
Table 1) may reflect its relatively recent invention and
Crystal Structure of SARS-CoV ORF-9b
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coupling to the essential N-gene.
Support for this general hypothesis comes from a
system which shares some similarity with the case pre-
sented here: in lentiviruses, the vpu and env genes—
although not strictly alternative ORFs—share a consider-
able overlapping region (Figure 5C). Similar to ORF-9b,
vpu encodes a small accessory protein which is present
only in a subfamily of lentiviruses (namely, human immu-
nodeficiency virus type 1, HIV-1). Although various mo-
lecular functions have been described for the protein,
its precise role in HIV-1 pathogenesis remains unclear
(Hout et al., 2004). In the vpu gene, the region which
overlaps with the neighboring env gene encodes its
cytoplasmic domain, whose structure has been deter-
mined by NMR (Willbold et al., 1997). This small domain
shows two well-defined helical regions and, like ORF-
9b, a considerable amount of poorly defined structure
(Figure 5C).
Conclusions
The structure of ORF-9b, an intertwined dimer with
an amphipathic outer surface and a long hydrophobic
lipid binding tunnel, suggests how this protein may
interact, via an unusual anchoring mechanism, with
compartments of the ER-Golgi network to act as an ac-
cessory protein during the assembly of the SARS virion.
These unusual structural and functional properties are
probably a reflection of the distinct evolutionary trajec-
tory of alternative open reading frames. Indeed, we pro-
pose that the constraints under which alternative open
reading frames evolve give rise to characteristic struc-
tural features, most importantly the potential for novel
folds and structural disorder. While further studies and
structures will be required to test this hypothesis, alter-
native open reading frames provide powerful model sys-
tems to test ideas about protein folding and evolution.
Experimental Procedures
Cloning and Production of Selenomethionine-Labeled Protein
for Structural Studies
The coding sequence of SARS-CoV ORF-9b was amplified by PCR
(forward primer: 50-GGGGACAAGTTTGTACAAAAAAGCAGGCTTC
GAAGGAGATAGAACCATGCATCACCATCACCATCACATGGACCC
CAATCAAACCAACG-30; reverse primer 50-GGGGACCACTTTGT
ACAAGAAAGCTGGGTCTCATTTTGCCGTCACCACCACG-30). The
forward primer encodes a start codon and hexahistidine tag N-ter-
minal to the gene and both forward and reverse primers contain
the attB site of the Gateway cloning system (Invitrogen). The PCR
fragments were subcloned into the pDEST14 plasmid (Invitrogen).
For expression of the selenomethionine-labeled protein, the
pDEST14 plasmid was transformed into E. coli strain Rosetta pLysS
(Novagen). Cultures were grown in selenomethionine media (Molec-
ular Dimensions) spiked with 1% glucose as well as lysine, threo-
nine, and phenylalanine (100 mg/ml each) and leucine, isoleucine,
valine, and selenomethionine (50 mg/ml each). Cells were grown at
310 K until an OD595 nm of 0.6 was reached, and then cooled to
293 K for 30 min. Expression was induced by the addition of iso-
propylthiogalactoside to a final concentration of 0.5 mM, and the
cultures were grown for a further 20 hr at 293 K. The cells were har-
vested by centrifugation at 12,000 3 g for 30 min and the bacterial
pellets were resuspended in 50 mM Tris-HCl (pH 8.0), 500 mM
NaCl, 1% Tween-20, 10 mM imidazole. The cells were lysed using
a cell disruptor (Constant Systems) and the sample was clarified
by centrifugation at 30,000 3 g for 30 min. To the supernatant,
2 ml of Ni-NTA superflow (Qiagen) was added and the sample was
stirred for 2 hr at 4ºC. The Ni-NTA beads were subsequently washedwith 50 mM Tris-HCl (pH 8.0), 500 mM NaCl, 20 mM imidazole and
protein was eluted in 50 mM Tris-HCl (pH 8.0), 500 mM NaCl,
500 mM imidazole. The eluted material was further purified by gel fil-
tration in 50 mM Tris-HCl (pH 8.0), 200 mM NaCl, 1 mM dithiothreitol
using a HiLoad 16/60 Superdex 200 column (Amersham Biosci-
ences). Full selenomethionine incorporation of the purified protein
was confirmed by mass spectrometry (data not shown).
Crystallization and Data Collection
Crystallization was carried out using a Cartesian robotic dispensing
system (Genomic Solutions) (Walter et al., 2005) and crystal growth
was monitored using the OPPF storage and imaging system (Mayo
et al., 2005). Diffraction quality crystals grew within 1–2 days in
300 nl sitting drops containing 6.3 mg/ml purified ORF-9b protein,
11% PEG-3350, 66 mM MgCl2, 33 mM Tris-HCl (pH 8.2), 20 mM
NAD equilibrated against a reservoir solution of 32% PEG3350,
200 mM MgCl2, 100 mM Tris-HCl (pH 8.2).
Crystals were cryoprotected in perfluoropolyether oil PFO-X125/
03 (Lancaster) and flash-frozen in liquid nitrogen (100 K). Single-
wavelength anomalous diffraction data were collected at the ESRF
beamline BM14 (Grenoble, France) and processed using the pro-
grams DENZO and SCALEPACK (Otwinowski and Minor, 1997).
The data were weak, especially at higher resolution, as reflected in
the poor R factors (Table 1); however, the high redundancy means
that the merged data were reasonably reliable.
Model Building and Refinement
The selenium substructure was solved using the programs
HKL2MAP and SHELXD (McRee, 1999; Pape and Schneider, 2004;
Schneider and Sheldrick, 2002; Sheldrick, 2002). Phase refinement
was carried out using SHARP (de La Fortelle and Bricogne, 1997),
maps were calculated using CCP4 programs (CCP4, 1994), sol-
vent-flattened using Pirate (Cowtan, 2000), and averaged using
GAP (J.M.G. and D.I.S., unpublished program). The presence of par-
tially disordered regions, together with the complex topology of the
protein, made the interpretation of the crystallographic data chal-
lenging. Model building and refinement used the programs Coot
(Emsley and Cowtan, 2004) and CNS (Bru¨nger et al., 1998). Initial re-
finement imposed strict 8-fold noncrystallographic symmetry (NCS)
constraints. In further rounds of refinement, 8-fold NCS restraints
were used. Data processing, refinement, and model building statis-
tics are shown in Table 1.
Calculation of the Hydrophobic Pore Dimensions
and Ligand Occupancy
The dimensions of the pockets of the structures of ORF-9b, polio-
virus (Filman et al., 1989), and human CD1b (Gadola et al., 2002)
were determined as the volume accessible to solvent probe with a di-
ameter of w1.4 A˚. For the calculation of the ligand volume, only
those ligand atoms located within the pore were included (atom
diameter, w1.4 A˚). All calculations were carried out using the pro-
gram VOLUMES (R.M. Esnouf, unpublished computer program,
personal communication).
Characterization of the Lipid Ligand by Mass Spectrometry
Concentrated purified ORF-9b protein was added to a chloroform-
water two-phase mixture and vortexed. After a 5 min equilibration
at room temperature, the hydrophilic phase was removed. The hy-
drophobic phase containing the ligand molecule was diluted into
a mixture of chloroform, methanol, and water (10:10:3) and analyzed
by positive ion electrospray mass spectrometry on a Waters-Micro
Q-TOF mass spectrometer.
Purification under Denaturing Conditions, Refolding,
and Biophysical Experiments
ORF-9b protein was expressed in E. coli as described in Experimen-
tal Procedures. The protein was then purified under denaturing con-
ditions as follows: cells were harvested by centrifugation at
12,000 3 g for 30 min and the bacterial pellet was resuspended in
6 M guanidine hydrochloride, 50 mM Tris-HCl (pH 8.0), 300 mM
NaCl, 1% Tween-20, 10 mM imidazole. The cells were lysed by son-
ication and the sample was clarified by centrifugation at 30,000 3 g
for 30 min. To the supernatant, 2 ml of Ni-NTA superflow (Qiagen)
was added and the sample was stirred for 2 hr at 4ºC. The Ni-NTA
Structure
1164beads were then washed with 6 M guanidine hydrochloride, 50 mM
Tris-HCl (pH 8.0), 300 mM NaCl, 20 mM imidazole and protein was
eluted in 6 M guanidine hydrochloride, 50 mM Tris-HCl (pH 8.0),
300 mM NaCl, 500 mM imidazole.
The protein was refolded by rapid dilution into 200 mM Tris-HCl
(pH 8.0), 1 M L-arginine, 0.1 mM phenylmethylsulfonylfluoride and
incubated for 24 hr at 4ºC. The refolding mixture was then concen-
trated and purified by gel filtration in 50 mM Tris-HCl (pH 8.0), 200
mM NaCl using a HiLoad 16/60 Superdex 200 column (Amersham
Biosciences). The elution position of refolded ORF-9b was identical
to that of natively purified protein.
Mass spectrometry analysis confirmed that refolded ORF-9b con-
tained only trace amounts of the lipid ligand (data not shown). Dy-
namic light scattering revealed that both refolded and natively puri-
fied protein have similar hydrodynamic behavior (Rhnatively purified =
2.27; Rhrefolded = 2.23) and analytical ultracentrifugation of refolded
ORF-9b gave a profile similar to that shown in Supplemental Data.
To test the effect of the lipid removal on the stability of the protein,
we carried out a ThermoFluor assay (Lo et al., 2004; Pantoliano et al.,
2001). In this experiment, ORF-9b was heated from 20ºC to 95ºC in
the presence of a fluorescent dye, SYPRO Orange (Molecular
Probes). As the protein unfolds, hydrophobic residues become sol-
vent exposed, leading to an increase in the fluorescence of the dye,
measured in a real-time PCR machine (Bio-Rad Opticon 2).
ORF-9b Expression in Mammalian Cells
N- and C-terminally hexahistidine-tagged ORF-9b constructs were
prepared by PCR and subcloned into the mammalian expression
vector pLEXm (Aricescu et al., 2006) for transient expression tests.
For the subcellular localization analysis, the ORF-9b constructs
were transfected into COS7 cells grown on four-well BD Falcon
glass culture slides (BD Biosciences) using Lipofectamine (Invitro-
gen). The cells were processed for immunofluorescence 48 hr later.
Briefly, the procedure was as follows: cells were fixed in 4% parafor-
maldehyde, permeabilized with 0.2% Triton X-100, and blocked with
a mixture of 1% bovine serum albumin (BSA) and 0.25% Triton X-100
(all solutions were made in PBS [pH 7.4], and all incubations were
done at room temperature). The His-tagged ORF-9b was detected
using the penta-His Alexa Fluor 555 monoclonal antibody (Qiagen)
diluted 1:150 in PBS containing 3% BSA and 0.05% Triton X-100.
The slides were washed, mounted in FluorSave reagent (Calbio-
chem), and imaged using a Nikon Eclipse TE2000U inverted micro-
scope. Differential interference contrast and epifluorescence im-
ages were taken using a 603 oil objective with a Hamamatsu Orca
285 CCD camera and processed with IP Lab imaging software.
ORF-9b expression was also analyzed by Western blotting.
HEK293T cells were transiently transfected with the ORF-9b His-
tagged constructs, collected 48 hr later, and lysed by repeated pas-
sage through a 22G needle and centrifuged for 10 min at 3000 g.
Samples were loaded in a 15% acrylamide gel, separated by SDS-
PAGE, and electroblotted onto a Hybond-C nitrocellulose mem-
brane (Amersham Pharmacia Biotechnology). The membrane was
blocked overnight in 5% skimmed dry milk in PBS and probed for
1 hr at room temperature with the penta-His monoclonal antibody
(Qiagen; 1:1000 dilution). The secondary antibody used was goat
anti-mouse IgG (Fc-specific) horseradish peroxidase (Sigma;
1:2000 dilution). Chemiluminescence detection was performed
using the ECL kit (Amersham Pharmacia Biotechnology).
Figures
Figures were generated with Bobscript (Esnouf, 1997) and PyMOL
(DeLano, 2002) and rendered with POV-Ray (Persistence of Vision
Ltd., Williamstown, Victoria, Australia).
Supplemental Data
Supplemental Data include analytical ultracentrifugation results and
sequence alignments and are available with this article online at
http://www.structure.org/cgi/content/full/14/7/1157/DC1/.
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